Monday, April 23, 2012

Jury hits Pfizer with $4m damage award in Prempro case.



Bloomberg News (4/21, Feeley) reported that Pfizer "must pay at least $4 million in damages to a woman who developed breast cancer after taking the company's Prempro menopause drug, a jury in Connecticut ruled. Jurors in federal court in New Haven ruled that Pfizer's Wyeth unit is liable for causing Margaret Fraser's cancer and that Prempro is an 'unreasonably dangerous product,' Greg Bubalo, one of Fraser's attorneys, said yesterday. The panel also found that Wyeth should pay punitive damages over its handling of the drug." Bloomberg also noted that Wyeth and Upjohn have lost 11 of 20 Prempro verdicts since 2006, although some awards were later reduced or voided. 

No comments: